The rest of the 100: Gary Fingerhut, executive director of Cleveland Clinic Innovations
Month: October 2014
Powerlist2014: Kay Enjoji, TEL Venture Capital
The rest of the 100: Kay Enjoji, president of TEL Venture Capital
Powerlist2014: Kai Engelhardt, Mahle Corporate Venture Capital
The rest of the 100: Kai Engelhardt, head of Mahle Corporate Venture Capital
Powerlist2014: Scott Darling, EMC
The rest of the 100: Scott Darling, Senior Vice President at EMC
Powerlist2014: Barbara Dalton, Pfizer Ventures
Barbara Dalton has worked at Pfizer’s corporate venturing unit for the past seven years as vice-president.She joined Pfizer from EuclidSR Partners, a venture firm backed by UK-based pharmaceutical company GlaxoSmithKline, where she worked from 2000 to 2007. Before this she was at GlaxoSmithKline’s corporate venturing unit SR One for seven years. Dalton has a PhD in microbiology and immunology from… Continue reading Powerlist2014: Barbara Dalton, Pfizer Ventures
Powerlist2014: Peter Cowley, Martlet
The rest of the 100: Peter Cowley, investment director for Martlet
Powerlist2014: Iain Cooper, Schlumberger
The rest of the 100: Iain Cooper, manager of technology investments at Schlumberger
Powerlist2014: Urs Cete, Bertelsmann Digital Media Investments
The rest of the 100: Urs Cete, head of Bertelsmann Digital Media Investments
Powerlist2014: Ignaas Caryn, KLM
The full 100: Ignaas Caryn, director of innovation and venturing at KLM
Powerlist2014: Adam Brotman, Starbucks
The full 100: Adam Brotman, chief digital officer at Starbucks
Powerlist2014: Fred Brothers, FIS
The rest of the 100: Fred Brothers, chief innovation officer at FIS
Powerlist2014: Michael Blaustein, DuPont Ventures
The full 100: Michael Blaustein, managing director of DuPont Ventures
Gainsight to benefit from $25m series C
Salesforce-backed marketing software developer Gainsight has raised $25m in a series C round that brought its total equity funding to $54m.
Great Basin refills coffers with $8m IPO
Life sciences company Great Basin, which closed a $7.6m series D round featuring Hitachi Chemical in April, has raised more than $8m from its initial public offering.